Mercy BioAnalytics Receives FDA Approval to Initiate Prospective Pivotal Study of Evident™Ovarian Cancer Screening Test
IDE approval enables initiation of the pivotal Safety in Ovarian Cancer for Average-Risk Women – Analysis ("SOARA") Clinical Validation Study following Institutional Review Board approval WALTHAM, Mass., Sept. 21, 2026 /PRNewswire/ -- Mercy BioAnalytics, Inc. ("Mercy" or the "Company"), a...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- WESTGATE LAS VEGAS RESORT & CASINO ANNOUNCES NEW 2027 DATES FOR BARRY MANILOW'S RECORD-BREAKING LAS VEGAS RESIDENCY
- STATEMENT FROM SEAN M. O'BRIEN ON PARAMOUNT-WARNER BROS. MERGER SETTLEMENT
- Real Estate Expert Nathan Abbott Explains What to Know Before Buying a Destin Vacation Home in HelloNation
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →